What's the big deal with rare earth elements? – DW – 06/13/2025
Rare earth elements are a group of 17 chemical elements that play an often small but irreplaceable role in many essential modern technological products.
Smartphones, flat-screen TVs, digital cameras and LEDs all rely on them but arguably one of their most important uses is in the making of what are known as permanent magnets.
These components can retain their magnetic properties for decades, and because they are so strong, they can be much smaller and lighter than any non-rare-earth alternatives currently available. As a result, they are critical to the construction of electric vehicles and wind turbines.
But the uses for rare earth elements, also known as REEs, do not stop there. They are also key to a huge range of defense technologies — from fighter jets to submarines and laser range finders.
This strategic importance, both for commerce and defense, is part of what makes them so valuable. Neodymium and praseodymium, the most important REEs for permanent magnets, currently go for around €55 ($62) per kilogram. Terbium can sell for a kilo price of up to €850.
Neodymium: The metal driving the energy transition
To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video
Where do they come from?
The 17 elements are not as 'rare' as their collective name might imply. In fact, they're very common, with trace amounts being found all over the world.
The challenge comes in finding areas with high enough concentrations to make extraction financially viable. Right now, according to US Geological Survey data, 70% of the world's rare earth elements are mined in China, the vast majority coming from the Bayan Obi mine in the country's north.
This single source is orders of magnitude larger than the next biggest deposits on the planet — such as Mount Weld in Australia and Kvanefjeld in Greenland — and contains large quantities of all the rare earth elements used to make magnets.
Once they're out of the ground, they undergo a highly specialized process of separation and refinement to turn them into usable compounds. This too, largely takes place in China, meaning the country doesn't only provide most of the world's rare earth metals, but most of its magnets too.
Rare earth elements are shipped in containers of soil such as here at Lianyungang port in China's Jiangsu province Image: REUTERS
This monopoly becomes even more powerful with certain types of the 17 REEs, which are split into three groups: light, medium and heavy, roughly based on their atomic value.
The lighter elements are typically less valuable and easier to source, with the magnet ingredients Neodymium and Praseodymium being the exceptions. Between 80-100% of the EU's supply of elements from this group come from China.
And for the heavier elements, which are much less abundant and require an even more specialized separation process, Europe sources 100% from China.
What happens if China cuts off access?
China's monopoly has many Western nations concerned about future access. So in recent years, the US and EU have responded by starting the process of building internal supplies of rare earth elements and other critical materials.
In 2024, the EU signed the Critical Raw Materials Act, which sets non-binding targets for the volume of critical materials the EU should produce itself by 2030. It also allows the bloc to designate 'strategic projects,' both within the EU and with close allies such as Norway, as a way of to ensure access to funding, boost public acceptance and fast track approvals and permits.
Meanwhile, the US defense department has been investing heavily in domestic companies since 2020 and has set a goal of creating an internal 'mine-to-magnet' supply chain by 2027.
The US and EU have both expressed interest in untapped sources of rare earth elements.
Ukraine and Greenland have become areas of key interest for US President Donald Trump. Both have very large potential deposits that are currently hard to get to, leaving the future of access to rare earth elements for Western countries uncertain.
Edited by: Tamsin Walker
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
DW
14 hours ago
- DW
Late-life depression: Learn to spot the signs early – DW – 07/25/2025
Depression goes undiagnosed when symptoms are mistaken for age-related physical illnesses. We need to treat mental health issues earlier in life. It is perhaps the last place you would expect to find a generational divide, but even in mental health, we (those of us of a certain age) are told, "We (those of us of a younger age) are more aware of mental health than you" — as if awareness alone could remedy depression. There is actually some truth to this. "There are shifts in younger generations and also in older generations. But unfortunately mental health is still very stigmatized for older adults," said Pascal Schlechter at the Institute of Psychology, University of Münster, Germany. "It's quite a big step [for some people] to admit, 'I have a mental health problem and I want to talk about it.'" But it's not only older patients who lack awareness or a willingness to talk about depression. It can also be their doctors, who may misdiagnose a mental health problem as a physical one, common when you grow old. "If a 30-year-old tells you they've stopped going out and are withdrawing [from social interaction], you would ask them, 'Is anything wrong with your mental health? Are you depressed?'," said Schlechter. "But with an older person, you might say, 'You're fatigued. It's just part of the normal aging process. Just rest.'" To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video The generational divide closes when we talk about symptoms of depression — there is little to no difference in depression between younger and older adults. While at Cambridge University in the UK, Schlechter co-published a paper on the development of depressive symptoms in older adults, based on the results from a longitudinal study that tracked the progress of more than 11,000 people over a period of 16 years. Schlechter and colleagues found the same symptoms in older adults as in younger adults: Patients expressed they , or that , they , had , or felt . However, they noted: "In older adults, depression often presents with more somatic symptoms than in younger populations." When we spoke in July 2025, Schlechter added: "Medical or somatic symptoms may be part of a depression, but [older adults] often misattribute these symptoms to their aging process. This can lead to delayed recognition, [and as a result] their depression may manifest more chronically." So, there is that difference: Whether it's due to a lack of awareness among patients and physicians, or stigma, depression can be worse for older people. That may be because the depression is combined with — or, in part, "triggered" by — a somatic (physical) illness, or symptoms of depression were left unaddressed earlier in life — perhaps also due to a lack of awareness or stigma. As with most illnesses the earlier depression or anxiety are diagnosed, the better the chances of treating them. Some social factors also contribute to depression. As we enter late life, we are often forced to adjust to changes in our social status, our identity through work or elsewhere in a community, and people start dying around us. We may even experience abuse from our carers, as highlighted information from the World Health Organization on depression — another, potential contributing factor. All these things can bring what may have been a mild, latent depression to the fore in a chronic and severe way. There is a sense when talking to experts in the field that physicians may prefer to tackle physical ailments in older adults than mental ones. No matter what age a person is, depression is difficult to treat. But when older adults present with both physical and mental health problems, it is even harder. "In both poorer and richer health systems in Europe, one of the main instruments we have to deal with depression is medication," said Albino Oliveira-Maia, who heads the Neuropsychiatry Unit at the Champalimaud Foundation in Lisbon, Portugal. "When treating older adults [with] medication, [there is a] higher likelihood for interaction with other medication and for toxicities [to occur]," Oliveira-Maia told DW. "That might mean physicians pay more attention to physical health problems than mental health." But medication is not the only treatment for depression — there are also a range of psychotherapy options, or so-called talk therapies, including cognitive behavioral therapy, and many others, specific to a patient's situation. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video One aspect of depression we have not touch on yet is suicide. Suicide affects all groups of people, young and old, male and female. But regulation often prevents people from participating in research if they are known to have suicidal thoughts or show suicidal behavior. And that means there is a lack of understanding and knowledge among researchers. "This is obviously an ethical concern," said Oliveira-Maia. "It's an act of generosity to participate in a research program, so we need to protect the people. But in doing that, there are sometimes consequences that lead to slower progress for some of the patients that are most in need." People over 65 years can also be excluded from trials if they have existing medical conditions, such as vascular lesions in the brain, said Oliveira-Maia. Scientifically, this makes sense, even if only from a cold, unemotional perspective: If people die or their illnesses worsen during a trial, it can make it impossible for other teams to verify the results — which is a standard process and safety net in research, especially in the development of new medication. Both Schlechter and Oliveira-Maia have reservations about awareness campaigns, and specifically about self-diagnosis, which can go either way — a younger person may be more inclined to say, "Yes, I have a mental health problem" even if they don't, and an older person may deny all the signs. "For younger generations, there is more public awareness due to social media. And there are good campaigns that provide valid information," said Schlechter. "But there's also a lot of misinformation out there." Oliveira-Maia, meanwhile, is concerned about people misdiagnosing themselves, whether they are young or old. "While [they are] valuable, there is also some data to suggest that the awareness campaigns can in themselves lead to misclassification in that some people that are healthy can value their normal symptoms of sadness and anxiety as a mental health problem." The solution, as always with any illness or symptom that concerns you, is to speak to a health professional you can trust.
Int'l Business Times
16 hours ago
- Int'l Business Times
Meta To Ban Political Ads In EU Due To Bloc's 'Unworkable' Rules
Meta on Friday said it will be forced to ban political advertising on its platforms in the European Union from October because of rules the Facebook and Instagram owner called "unworkable". The EU has a bolstered legal armoury to rein in Big Tech, against which Meta has hit out with the support of the US administration under President Donald Trump. "This is a difficult decision -- one we've taken in response to the EU's incoming Transparency and Targeting of Political Advertising (TTPA) regulation," the company said. Political, electoral and social issue advertising will no longer be allowed from October in the bloc, it said, because of "unworkable requirements" under the new rules. "Unfortunately, the TTPA introduces significant, additional obligations to our processes and systems that create an untenable level of complexity and legal uncertainty for advertisers and platforms operating in the EU," Meta added. The EU says its political advertising rules seek to increase transparency in online advertising after Facebook's Cambridge Analytica scandal, which came to light in 2018. Cambridge Analytica was a consulting firm that was found to have improperly accessed personal data from millions of Facebook users for targeted political advertising, particularly during the 2016 US election and Brexit referendum. The change is set to impact Meta's flagship platforms Facebook and Instagram, as well as WhatsApp -- which is largely ad-free but announced in June it would be introducing new advertising features in some parts of the app. Meta said it was "not the only company to have been forced into this position". Google last year announced it would also prevent political advertising in the EU from October 2025 because of the "significant new operational challenges and legal uncertainties". Meta CEO Mark Zuckerberg has been highly critical of European rules, accusing Brussels in January of "censorship" and equating EU fines against the company to tariffs. The latest row between Meta and the EU has been over the firm's "pay or consent" system. The EU imposed a 200-million-euro ($235-million) fine in April after concluding Meta violated rules on the use of personal data on Facebook and Instagram. The company faces additional daily penalties if it does not make changes, with Brussels yet to decide whether Meta has modified the platforms enough to avoid more fines. Facebook and Instagram also face investigations under the EU's mammoth content moderation law known as the Digital Services Act.
DW
2 days ago
- DW
Tattoo tech may help detect drink spiking – DW – 07/23/2025
A new material science development could provide an effective way to detect party drugs used to commit sexual assault. A temporary "tattoo" could provide partygoers looking for a safe night out with a secret indicator to detect drugs often used to spike drinks in public bars and clubs. Rohypnol — also called a "roofie" — and GHB, sometimes called "liquid ecstasy" or "fantasy," are club drugs used, often by young people, in bars and nightclubs, raves and other nightlife settings. It is an illegal drug in many places, including the United States, UK and Australia. While certain doses of these club drugs can produce a feeling of relaxation or euphoria, excessive doses can lead to symptoms of drowsiness, slurring of speech, loss of motor function, confusion and memory impairment. Overdose and toxicity are also possible. Drug regulators have also identified both drugs as the toxins of choice for offenders seeking to spike drinks, render their victims unconscious or close to that, and then sexually assault them. Because these are short-lived, tasteless and colorless drugs, it's especially difficult for those wanting to have a safe night out to know if their drink has been spiked. However, a new report published in the American Chemical Society in its journal has described an innovation from a South Korean research group that could make drug identification practically seamless. There are already products that allow people to identify whether a drink has been spiked. These appear as strips that can be dipped into a drink, with a color change indicating the presence of an unwanted chemical. However, such a technique can take minutes and could leave a person vulnerable to other social dangers with such an obvious testing method. The new rapid test developed by materials scientists funded by the South Korean government could offer an alternative. Looking like a tattoo, but in actuality a removable sticker, the new product could provide an opportunity to quickly and subtly identify the presence of GHB. Embedded in the silicone sticker film is a solution containing an iodide indicator called BHEI. When exposed to a solution containing GHB, the indicator changes from yellow to red. According to reported results, stickers changed color almost instantaneously when exposed to drops of GHB in whisky, vodka, beer or coffee. For those wearing the sticker, they would only need to expose their marker to a single droplet of their drink for the change to take place. It was sensitive enough to detect 0.01 milligrams of GHB per milliliter. "This innovation represents a proactive and accessible solution for preventing drug-facilitated sexual assault, enhancing personal safety, and fostering a sense of control and awareness in high-risk environments," the authors wrote in the study. To view this video please enable JavaScript, and consider upgrading to a web browser that supports HTML5 video It's not the first time that sensors have been developed to detect date rape drugs. More than a decade ago, a group from the National University of Singapore developed a fluorescent sensor platform that could be formed into drink stirrers and straws to indicate drinks spiked with GHB. A US startup had previously invented a quick test platform that tested for several drugs using a testing disc. But rapid testing products will likely need to be developed further before going to market. Kabrena Rodda, a forensic toxicologist at the Pacific Northwest Laboratory in the US, said some spot tests can be unreliable. "Unfortunately, spot detection methods such as these can often have high false positive rates — that is, telling you it detected the drug when it actually is not there," Rodda, who was not involved in the new study, told DW in an email. "This can lead people to avoid drinks that may be safe, which may in turn lead to an inaccurate belief that GHB is being spiked in people's drinks." However, Rodda said the sticker test developed by the Korean researchers was "praiseworthy and important." A venture company has now been established to try and bring the product to market in South Korea. But customization and adaptability to other target drugs is currently limited. "Since a custom mold must be made and filled with agarose gel containing the GHB chemical receptor, there may be limitations in freely designing shapes like real tattoos," Gyeong-Ji Kim, the study's lead author based at Sungkyunkwan University in South Korea, told DW. "Customization is possible to some extent, but it is technically constrained. "We have not yet developed chemical receptors for detecting other drugs. However, if receptors for substances such as opioids or synthetic cannabinoids are developed in the future, we believe they can be integrated into our tattoo sticker platform."
